Holen Sie sich die Stockscreener-App
1.09
21.10%
0.1899
Finanzdaten der Inovio Pharmaceuticals Inc-Aktie (INO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-06-30 | 2024-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | 0.0653 | 0.1008 | - |
Operating Expenses
|
8.12%
21.21
|
23.08 | 25.12 | 33.30 | 31.48 |
| Benefits Costs and Expenses |
-
|
- | - | - | - |
| Costs And Expenses |
8.12%
21.21
|
23.08 | 25.12 | 33.30 | 31.48 |
| Operating Income/Loss |
8.12%
-21.21
|
-23.08 | -25.05 | -33.20 | -31.48 |
| Income/Loss From Continuing Operations Before Tax |
93.44%
-45.50
|
-23.52 | -19.69 | 0.1008 | -30.47 |
| Income/Loss From Continuing Operations After Tax |
93.44%
-45.50
|
-23.52 | -19.69 | -32.24 | -30.47 |
|
Net Income/Loss
|
93.44%
-45.50
|
-23.52 | -19.69 | -32.24 | -30.47 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
34.35%
52.17
|
38.83 | 38.61 | 27.20 | 23.29 |
| Diluted Average Shares |
34.35%
52.17
|
38.83 | 38.61 | 27.20 | 23.29 |
| Basic Earnings Per Share |
42.62%
-0.87
|
-0.61 | -0.51 | -1.19 | -1.31 |
| Diluted Earnings Per Share |
42.62%
-0.87
|
-0.61 | -0.51 | -1.19 | -1.31 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):